During controlled clinical trials, one case of overdose with Pioglitazone was reported. A male
patient took 120 mg per day for four days, then 180 mg per day for seven days. The patient
denied any clinical symptoms during this period. Return to top
In the event of overdosage, appropriate supportive treatment should be initiated according
to patient’s clinical signs and symptoms. Return to top
Adapted from the FDA Package Insert.